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What's already known about this topic? 
Individuals with compromised immune surveillance, including organ transplant 
recipients (OTRs) and chronic lymphocytic leukaemia (CLL) patients, are at increased 
risk of developing skin cancer. 




What does this study add? 
Detection of β-HPV and Merkel cell polyomavirus DNA in the skin lesions and hair 
bulbs from CLL patients without any evident reactivation at skin tumour sites indicates a 






Background. Research consistently demonstrates an increased incidence of skin cancer in the 
immunocompromised host, including patients with chronic lymphocytic leukaemia (CLL) and 
organ transplant recipients (OTRs). Active human beta papillomavirus (β-HPV) infection has been 
found in OTR skin lesions, suggesting their possible involvement in skin carcinogenesis. Although 
less frequent, Merkel cell polyomavirus (MCPyV) has also been reported in cases of skin cancer. 
Objectives. To investigate: i) potential correlations between patient clinical features and skin cancer 
development; and ii) the presence of β-HPV and MCPyV DNA, and viral protein markers in skin 
lesions and hair bulbs from CLL patients. 
Methods. The clinical features of 293 patients with CLL were analysed according to the presence or 
absence of skin lesions. β-HPV and MCPyV infection was investigated in skin lesions and hair 
bulbs from the study cohort by both PCR analysis and immunohistochemical screening.  
Results. No significant correlations were observed between any of the analysed haematological 
parameters and the development of skin cancer. PCR analysis revealed the presence of β-HPV and 
MCPyV DNA in skin tumours, and 83% of positivity for MCPyV DNA in hair bulbs, while 
systematic immunohistochemical analysis of all the lesions failed to detect any expression of the 
viral proteins β-HPV E4, L1 or MCPyV LTAg. 
Conclusion. Overall, our data indicate that carriage of  β-HPV and MCPyV in the lesional skin and 
hair bulbs from CLL patients, without any evident reactivation at skin tumour sites, represents 
coincidental rather than casual infection. This contrasts with our previous findings in relation to 





Chronic lymphocytic leukaemia (CLL) is one of the most common adult haematological 
malignancies.1 CLL patients exhibit a status of chronic immunodeficiency that shows some 
similarities to that typically observed in solid organ transplant recipients (OTRs) treated with 
immunosuppressive agents.2  Specifically, the risk of developing skin cancer is increased 8- to 13-
fold in CLL patients and 65- to 250-fold in OTRs, making cutaneous neoplasms the most frequent 
type of malignancy reported in both settings.2-4  
An increasing body of evidence suggests that human beta papillomaviruses (β-HPVs) are 
implicated in the pathogenic mechanisms underlying the development of skin cancer in patients 
with immune dysfunction.5  β−HPVs (e g, HPV5 and 8) are evolutionarily distinct from the genus 
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Alpha and appear to cause widespread unapparent or asymptomatic infections in the general 
population. The relationship between β-HPV infection and skin cancer has been clearly defined in 
patients with congenital immune defects, including epidermodysplasia verruciformis (EV), an 
autosomal recessive disease characterised by a predisposition to infection by specific β-HPV 
types.6,7 Despite these findings, a causal role of these viruses has been difficult to verify in non-EV 
patients because of their ubiquitous prevalence in the general population and their absence in some 
cancers. In recent studies, we demonstrated productive β-HPV infection in actinic keratosis and the 
adjacent pathological epithelium in skin cancer lesions from OTRs, thus pointing to β-HPV 
reactivation in this setting and its possible involvement in the process of skin carcinogenesis.8  
A causal role of Human Polyomaviruses (HPyVs), another family of small DNA tumour 
viruses, in the pathogenesis of skin cancer has also been envisaged.9  DNA of a novel HPyV, 
namely Merkel Cell Polyomavirus (MCPyV), was detected in the majority of investigated cases of 
Merkel cell carcinoma (MCC), a rare form of neuroendocrine carcinoma of the skin.9  MCPyV 
DNA has also been reported in skin cancer cases from both immunocompetent and 
immunosuppressed patients (OTRs).9,10 
The aims of this study were i) to correlate patient clinical features with the presence or 
absence of skin cancer in a cohort of 293 CLL patients; and ii) to evaluate the presence of β-HPV 




Materials and methods 
Study population and skin tumour specimens.  
This study was based on a consecutive series of 293 CLL patients admitted to the Division of 
Haematology between June 1985 and February 2011. The mean patient follow-up period was 78 
months. All patients provided informed consent in accordance with the local institutional review 
board requirements and Declaration of Helsinki guidelines. CLL diagnosis and the analysis of 
clinical and biological variables were performed as previously described.11 
 
β-HPV and MCPyV DNA detection 
DNA extraction from FFPE blocks and hair samples was performed as previously reported.6 A 
nested PCR method was used to detect β-HPV DNA.12  For β-HPV genotyping, second-step PCR 
amplimers were purified and sequenced after cloning using the CloneJET PCR Cloning Kit 
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(Fermentas). For MCPyV DNA analysis, MCV-qPCR primers that amplify a 177 bp product within 
the stAg gene were used in an adapted protocol previously described.13 
 
Immunohistochemistry 
Consecutive 5 μm sections, cut from FFPE skin biopsy blocks, were dewaxed and rehydrated. 
Polyclonal antibodies against β-HPV E4 and L1 and the staining procedures used are described 
elsewhere.7,8  For MCPyV LTAg detection, we used the primary mouse monoclonal antibody 
CM2B4 (Santa Cruz Biotechnology).14 For assessment of histological features, hematoxylin and 
eosin staining was performed. 
 
Statistical analysis 
Categorical and continuous variables were analysed as previously described.11  Statistical 




The clinical features of the study population, stratified according to the presence or absence of 
skin cancer, are presented in Table 1. Forty of the 293 CLL patients (14%) developed at least one 
skin lesion, with a total number of 96 lesions identified. Histologically, the skin cancer lesions were 
diagnosed as follows: squamous cell carcinoma (SCC), n=16; basal cell carcinoma (BCC), n=35; 
actinic keratosis (AK), n=17; Bowen’s disease (BD), n=3; keratoacanthoma (KA), n=3; seborrheic 
keratosis (SK), n=13; wart, n=2; non-epithelial tumours, n=6 (melanoma, n=2; fibroxanthoma, n=1; 
Kaposi’s sarcoma, n=3). The proportion of males was significantly higher among patients with skin 
cancer. No significant correlation was found between any of the analysed haematological 
parameters and the presence or absence of skin cancer. Skin cancer developed after CLL diagnosis 
in 29 patients, with a mean time from CLL diagnosis of 63 months; while 11 patients were 
diagnosed with skin cancer prior to CLL diagnosis (mean time, 80 months). The majority of skin 
lesions occurred in sunlight-exposed body sites, mostly the head and neck region (n=51, 53%).  
DNA was extracted from at least one biopsy for each histological type per patient, providing a 
total of 50 samples, and subjected to β-HPV genotyping. As shown in Table 2, the majority of the 
benign lesions (namely warts and SK) showed higher percentage of positivity in comparison with 
tumours with an overall positivity of 38%.  
Next, to investigate whether productive β-HPV infection could be visualised by means of 
viral protein detection (as previously reported for skin lesions from OTRs), tissue sections from all 
50 FFPE blocks were stained with antibodies against β-HPV E4 and L1 proteins. No lesion 
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displayed any positivity for either marker and tissue histology did not reveal any virus-related 
cytopathic effects. The same samples were also screened for MCPyV DNA by PCR analysis. 
Eleven specimens (22%) were positive, distributed among the lesion types as follows: 6 AK, 2 KA, 
1 SCC, 1 BD and 1 wart. Once again, all the specimens were screened for the expression of viral 
protein MCPyV LTAg, but none of them displayed any positive immunostaining for this viral 
marker.  
Since plucked eyebrow hair bulbs were also available for 46 patients of the study population 
(14 with and 32 without skin lesions), we extracted the DNA and ran PCR analysis for MCPyV and 
β-HPV DNA, applying an approach similar to that used for the skin biopsies. MCPyV DNA was 
found in 38 specimens (83%), while β-HPV DNA was present in all of them. 
 
Discussion 
The biological aggressiveness of skin cancer with respect to multiplicity and recurrences 
was confirmed in this CLL series, since 50% of the patients with skin cancer experienced multiple 
lesions (up to 18 in one case), and one patient developed a multi-relapsing BCC (5 relapses) on the 
forehead that was treated by Mohs surgery. 
While PCR analysis revealed the presence of β-HPV and MCPyV DNA in a significant 
proportion of tumours (38% and 22% respectively), systematic immunohistochemical analysis of all 
the lesions failed to detect any expression of the viral proteins β-HPV E4, L1 or MCPyV LTAg. In 
addition, the prevalence of MCPyV DNA in hair bulbs was higher than those reported in HIV 
patients (83% v.s. 50% respectively).15 
Using antibodies against β-HPV E4, L1 or MCPyV LTAg, we showed that all the 
skin lesions from our study cohort of CLL patients were negative indicating that when the 
viral DNA was found in these tumours it was most likely a coincidental infection consistent 
with their ubiquitous asymptomatic presence in the general population. Although skin 
cancer arising in CLL patients may share some common risk factors with OTRs, they do not 
seem to be associated with β-HPV infection as reported in OTRs.8 
 
Supporting Information 
Supplementary materials and methods: Diagnosis of chronic lymphocytic leukaemia 
(CLL); β-HPV and MCPyV-DNA detection in formalin-fixed paraffin-embedded (FFPE) 
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